Executive Leadership
Co-Founder & Chief Executive Officer
Dr Lorena Lizarraga
Specialising in cell biology, nerve tissue engineering, electrospinning, and microfluidic blood-brain barrier modeling, Dr Lizarraga guides commercial operations and platform development. Her technical vision ensures our human-relevant systems deliver high-throughput, translatable compound data for global pharmaceutical partners.
Co-Founder & Chief Scientific Officer
Professor Gareth Cave
As key inventor and academic lead within Nottingham Trent University, Professor Cave provides scientific oversight and IP strategy. His pioneering work in nanostructured materials and dynamic culture technologies underpins our proprietary platform, accelerating animal-free drug discovery and safety assessment.
Initiate dialogue with our executive team
Our leadership team works directly with biotechnology sponsors and academic collaborators to define study objectives, custom assay requirements, and platform integration plans.